NVS NYSE
Novartis AG
1W: +2.1%
1M: +6.8%
3M: -1.3%
YTD: +13.2%
1Y: +20.3%
3Y: +76.1%
5Y: +123.7%
$156.86
+3.05 (+1.98%)
After Hours: $155.94 (-0.92, -0.59%)
Weekly Expected Move ±3.4%
$141
$146
$151
$156
$162
Credit Risk of going bust: lower than 80% of companies Debt: 14.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.81 (down 99%), Novartis AG would be worth roughly what it owes.
Total debt $49.01B against a stock market value of $292.35B.
Distance to default 9.62 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $28.61B (short-term plus half of long-term), stock volatility 27.6%; Altman Z'' 2.30. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $49.01B against a stock market value of $292.35B.
Distance to default 9.62 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $28.61B (short-term plus half of long-term), stock volatility 27.6%; Altman Z'' 2.30. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$56B
Revenue
+0.8% YoY
$13B
Net Income
-6.6% YoY
$16B
Free Cash Flow
-5.9% YoY
74.5%
Gross Margin
32.8%
Op. Margin
22.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE30.6%
ROA11.3%
ROIC16.8%
Valuation
P/E23.6
P/B7.1
EV/EBITDA15.3
Leverage
Debt/Equity1.18
Current Ratio0.86
Interest Cov.12.2x
Quality Scores
Piotroski F5/9
Altman Z3.57
Beneish M-2.53